Article

Rheumatology Network's Top 5: August 6, 2022

Author(s):

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending August 6, 2022.

FDA Approves Ustekinumab for Pediatric Patients with Psoriatic Arthritis

Patients with pediatric psoriatic arthritis will now have access to the first-in-class treatment option, ustekinumab.

Updated Vaccination Guidance for Patients with Rheumatic and Musculoskeletal Diseases

The American College of Rheumatology announced updated vaccination guidance for patients with rheumatic diseases, including expanding indications for certain vaccines for those receiving immunosuppressive medications, medication management, and vaccination delay.

How can Rheumatologists Prevent and Manage Burnout?

Whether it is leaning on the support of colleagues, mindfulness meditation, or jujitsu, rheumatologists weigh on how they personally prevent and manage symptoms of burnout.

What are the Current Challenges Contributing to Physician Burnout in Rheumatologists?

Besides the obvious stressors regarding the uncertainty of COVID-19 and implementation of telemedicine, other issues include the rheumatologist shortage, referred to as the “great resignation."

Rheumatoid Arthritis Quiz: Disease Activity Score

Assessing disease activity is an important part of a treat-to-target strategy. How much do you know about the different approaches? Take this quiz to find out.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
© 2024 MJH Life Sciences

All rights reserved.